TSHA
Taysha Gene Therapies, Inc. · Healthcare
4.65
6.41%(+0.28)
Prev. Close4.85
4.30%(+0.20)
Pre-marketLast Updated: — ET
52W L: $1.0552W H: $6.02
$4.69
CHG+0.15 (+3.30%)
H$4.86
L$4.01
VOL49M
TSHA (1h)
Taysha Gene Therapies, Inc. · Healthcare
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
1,655 SH @ $4.52
2026-02-04
Nagendran Sukumar
director, officer: President and Head of R&D
89,132 SH @ $4.75
2026-01-23
Nagendran Sukumar
director, officer: President and Head of R&D
26,918 SH @ $4.61
2026-01-26
Nolan Sean P.
director, officer: Chief Executive Officer
136,789 SH @ $4.75
2026-01-23
Nolan Sean P.
director, officer: Chief Executive Officer
41,312 SH @ $4.61
2026-01-26
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
78,968 SH @ $4.75
2026-01-23
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
23,849 SH @ $4.61
2026-01-26
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
359,000 SH @ $0.00
2026-01-12
